BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25714026)

  • 1. miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.
    Gao R; Cai C; Gan J; Yang X; Shuang Z; Liu M; Li S; Tang H
    Oncotarget; 2015 Mar; 6(8):6014-28. PubMed ID: 25714026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
    Xiao ZD; Jiao CY; Huang HT; He LJ; Zhao JJ; Lu ZY; Liu LX
    Int J Clin Exp Pathol; 2014; 7(7):4039-44. PubMed ID: 25120782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
    Ding L; Wang RY; Zhang F; Wu MS; Chen B; Sun KW
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1073-1081. PubMed ID: 38621914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
    Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
    Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines.
    Li M; Li H; Li C; Wang S; Jiang W; Liu Z; Zhou S; Liu X; McNutt MA; Li G
    Int J Cancer; 2011 Feb; 128(3):524-32. PubMed ID: 20473866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.
    Ohta K; Hoshino H; Wang J; Ono S; Iida Y; Hata K; Huang SK; Colquhoun S; Hoon DS
    Oncotarget; 2015 Feb; 6(5):3211-24. PubMed ID: 25633810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway.
    Wang H; Zhang Q; Cui W; Li W; Zhang J
    Cell Cycle; 2021 Oct; 20(20):2125-2136. PubMed ID: 34570663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
    Jiang J; Zhang Y; Guo Y; Yu C; Chen M; Li Z; Tian S; Sun C
    Oncotarget; 2015 Mar; 6(8):6359-72. PubMed ID: 25849943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
    Tu K; Liu Z; Yao B; Han S; Yang W
    Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The anti-apoptotic effect of cytoplasmic alpha-fetoprotein in hepatoma cells induced by all-trans retinoic acid involves activation of the PI3K/AKT signaling pathway].
    Zhu MY; Guo JL; Xia H; Li W; Lu Y; Dong X; Chen Y; Fu SG; Xie XJ; Li FS
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):837-42. PubMed ID: 25531381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
    Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
    Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments.
    Ohkawa K; Asakura T; Tsukada Y; Matsuura T
    Int J Oncol; 2017 Jun; 50(6):2180-2190. PubMed ID: 28498467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
    Kong G; Zhang J; Zhang S; Shan C; Ye L; Zhang X
    PLoS One; 2011 May; 6(5):e19518. PubMed ID: 21573166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oroxin B Induces Apoptosis by Down-Regulating MicroRNA-221 Resulting in the Inactivation of the PTEN/PI3K/AKT Pathway in Liver Cancer.
    Li N; Men W; Zheng Y; Wang H; Meng X
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31801250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN.
    Sun JF; Zhang D; Gao CJ; Zhang YW; Dai QS
    Med Sci Monit Basic Res; 2019 Oct; 25():218-228. PubMed ID: 31645540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
    Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y
    J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.